Media Summary: Dr. Phil Bonomi, from Rush University, discusses his perspective on side effects of targeted therapies as ... Dr. Phil Bonomi, from Rush University, provides his perspective on the likelihood that molecular ... The brave new world of the genome and genetics research is leading to the development of targeted cancer therapies that ...

David Berz Md Phd And - Detailed Analysis & Overview

Dr. Phil Bonomi, from Rush University, discusses his perspective on side effects of targeted therapies as ... Dr. Phil Bonomi, from Rush University, provides his perspective on the likelihood that molecular ... The brave new world of the genome and genetics research is leading to the development of targeted cancer therapies that ... Slower is Better: Progress Towards Neuroprotection in PD For more resources and information regarding anticancer targeted therapies:

Photo Gallery

David Berz, MD, PhD, and Philip Bonomi, MD Discuss Liquid Biopsies Versus Tissue Biopsies
David Berz, MD, PhD, and Philip Bonomi, MD Discuss Molecular Diagnostics in NSCLC
David Berz, MD, PhD, and Philip Bonomi, MD Discuss Benefits of Urine-Based Mutational Screening
David Berz, MD, PhD, and Philip Bonomi, MD Discuss Use of Liquid Biopsies Over Surgical Biopsies
David Berz, MD, PhD, and Philip Bonomi, MD Discuss Options After an Initial EGFR Exon 19 TKI Therapy
BERZ MD
New paradigms in cancer treatment: From bedside to bench and back again
ER-Positive MBC Research Update | 2024-2025 EMBRACE MBC Virtual Forum Series
GRACEcastUC102_Kidney_Dr. Bonomi on Targeted Therapy Toxicity Chemotherapy
GRACEcastUC088_Lung_Dr. Bonomi on Lung Cancer Targeted Therapies
Using emibetuzumab directed towards MET for the treatment of lung cancer
David H.  Vesole, M.D., PhD - MMRF Conference
Sponsored
Sponsored
View Detailed Profile
Sponsored
Sponsored